Herrington, W. G., Che, Z. J., Sardell, R., Roddick, A. J., Judge, P. K., Wanner, C., . . . Staplin, N. (2025). Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: An individual participant-level meta-analysis. The lancet. Diabetes & Endocrinology, 13(12), . https://doi.org/10.1016/S2213-8587(25)00222-0
Chicago-Zitierstil (17. Ausg.)Herrington, William G., et al. "Effects of Empagliflozin on Conventional and Exploratory Acute and Chronic Kidney Outcomes: An Individual Participant-level Meta-analysis." The Lancet. Diabetes & Endocrinology 13, no. 12 (2025). https://doi.org/10.1016/S2213-8587(25)00222-0.
MLA-Zitierstil (9. Ausg.)Herrington, William G., et al. "Effects of Empagliflozin on Conventional and Exploratory Acute and Chronic Kidney Outcomes: An Individual Participant-level Meta-analysis." The Lancet. Diabetes & Endocrinology, vol. 13, no. 12, 2025, https://doi.org/10.1016/S2213-8587(25)00222-0.